tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Stephen Willey, 154 are a BUY (71.3%), 60 are a HOLD (27.78%), 2 are a SELL (0.93%).
Analyst Stephen Willey works at STIFEL with a stock forecast success ratio of 47.75% fulfilled within 176.2 days on average.
Stephen Willey’s has documented 390 price targets and ratings displayed on 46 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MEIP, MEI Pharma at 12-Apr-2024.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $21 was fulfilled within 1 day with a profit of $4.15 (16.5%) receiving and performance score of 165.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
$1.52 (43.68%)
9
1 years 11 months 12 days ago
1/3 (33.33%)
$2.28 (83.82%)
2
Sell
6
2 years 3 months 12 days ago
3/4 (75%)
$-0.12 (-1.96%)
12
Hold
2 years 3 months 28 days ago
0/1 (0%)
$26.16 (77.30%)
Buy
40
2 years 4 months 9 days ago
1/1 (100%)
$6.16 (18.20%)
3
Which stock is Stephen Willey is most bullish on?
Which stock is Stephen Willey is most reserved on?
What Year was the first public recommendation made by Stephen Willey?
